Cross‐Talk Between Histamine H 2 Receptor and Glucocorticoid Receptor: Potential Implications in Acute Myeloid Leukemia Treatment
Open Access
- 14 September 2026
- journal article
- Published by Wiley in Pharmacology Research & Perspectives
- Vol. 14 (5)
Abstract
This study investigates the impact of histamine H 2 receptor activation on glucocorticoid receptor (GR)‐mediated transcriptional activity, as well as its effects on leukemic cell proliferation and chemotherapy resistance. We demonstrate that activation of the histamine H 2 receptor by its specific agonist, amthamine, enhances GR transcriptional activity induced by dexamethasone in both artificial promoter‐driven luciferase reporter assays and endogenous GR‐responsive genes. Mechanistically, histamine H 2 receptor signaling exerts a dual regulatory effect: an inhibitory influence mediated by cAMP and a stimulatory effect through inhibition of the PI3K‐AKT–mTOR‐S6K pathway and activation of the ERK pathway. Furthermore, while dexamethasone reduces leukemic cell proliferation at high doses, it increases it at lower concentrations, an effect that is abrogated by amthamine. Moreover, the combination of the glucocorticoid and the H 2 agonist reestablishes leukemic cell sensitivity to cytarabine, thereby restoring its cytotoxicity. Together, these findings offer insight into the molecular mechanisms and therapeutic potential of the interplay between histamine H 2 ligands and GR agonists, and may help guide dosage optimization and mitigate the well‐known side effects of glucocorticoid therapy, with potential clinical implications for the treatment of acute myeloid leukemia.Keywords
Funding Information
- Universidad de Buenos Aires (UBACYT‐20020190100015BA)
This publication has 43 references indexed in Scilit:
- Acute Myeloid Leukemia: 2025 Update on Diagnosis, Risk‐Stratification, and ManagementAmerican Journal of Hematology, 2025
- Novel inhibitors of phosphorylation independent activity of GRK2 modulate cAMP signalingPharmacology Research & Perspectives, 2022
- PI3K pathway is involved in ERK signaling cascade activation by histamine H2R agonist in HEK293T cellsBiochimica et Biophysica Acta (BBA) - General Subjects, 2016
- Histamine H2 Receptor in Blood Cells: A Suitable Target for the Treatment of Acute Myeloid Leukemia2016
- Glucocorticoid-Induced Proliferation in Untreated Pediatric Acute Myeloid Leukemic BlastsPediatric Blood & Cancer, 2016
- Crosstalk between Glucocorticoid Receptor and Nutritional Sensor mTOR in Skeletal MuscleCell Metabolism, 2011
- The human glucocorticoid receptor: Molecular basis of biologic functionSteroids, 2010
- Histamine H2 receptor overexpression induces U937 cell differentiation despite triggered mechanisms to attenuate cAMP signallingBiochemical Pharmacology, 2006
- The effect of steroid on myeloid leukemic cells: The potential of short-course high-dose methylprednisolone treatment in inducing differentiation, apoptosis and in stimulating myelopoiesisLeukemia Research, 2006
- Effects of methylprednisolone on human myeloid leukemic cells in vitroAmerican Journal of Hematology, 1999